Cleared Traditional

K160837 - MEDINET INCENTIVE SPIROMETERS - RESPIPROGRAM (FDA 510(k) Clearance)

Class II Anesthesiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K160837 · Medinet Srl · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2017
Decision
335d
Days
Class 2
Risk

K160837 is an FDA 510(k) clearance for the MEDINET INCENTIVE SPIROMETERS - RESPIPROGRAM. Classified as Spirometer, Therapeutic (incentive) (product code BWF), Class II - Special Controls.

Submitted by Medinet Srl (Milano, IT). The FDA issued a Cleared decision on February 23, 2017 after a review of 335 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5690 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Medinet Srl devices

Submission Details

510(k) Number K160837 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 25, 2016
Decision Date February 23, 2017
Days to Decision 335 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
196d slower than avg
Panel avg: 139d · This submission: 335d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code BWF Spirometer, Therapeutic (incentive)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5690
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - BWF Spirometer, Therapeutic (incentive)

All 107
Devices cleared under the same product code (BWF) and FDA review panel - the closest regulatory comparables to K160837.
InSee
K241152 · Tidal Medical Technologies, LLC · Aug 2025
AllPEP
K233855 · Enchant Tek Co. , Ltd. · Feb 2024
LungTrainer (MD2 & MD3)
K221058 · Lung Trainers, LLC · Jul 2023
Breathe+
K222018 · Peep Medical, LLC Dba Go2 Devices · Jun 2023
Hudson RCI Triflo II Incentive Deep Breathing Exerciser
K220565 · Medline Industries, Inc. · Oct 2022